Anxiety Common Among COPD Patients

Article

Levels of anxiety are up to three times higher in older adults with chronic obstructive pulmonary disease (COPD) than in patients without COPD.

Levels of anxiety are up to three times higher in older adults with chronic obstructive pulmonary disease (COPD) than in patients without COPD, according to findings published in COPD: Journal of Chronic Obstructive Pulmonary Disease.

Researchers from the University of Toronto studied a sample of more than 11,000 patients in order to investigate the independent relationship between COPD and anxiety in adults. The patients, who were aged 50 and older, were measured for sociodemographic factors, social support, health behaviors, sleep problems, pain, functional limitations and early childhood adversities. More than 700 adults reported their COPD diagnosis during the 2012 Canadian Community Health Survey.

The researchers found that one in 17 adults with COPD had anxiety within the past year, or about 5.8 percent. When the researchers adjusted for age, sex and race, the anxiety levels were four times higher for COPD patients than for those without (about 3.90). When the researchers adjusted for all 18 characteristics they measured for, the odds declined to 1.72 between COPD and non COPD patients.

“Even after accounting for 18 possible risk factors for GAD, individuals with COPD still had 70 percent higher odds of GAD compared to those without COPD,” lead author, Professor Esme Fuller-Thomson said in a press release.

Some of the leading risk factors for anxiety among COPD patients, the researchers reported, were lack of social support and exposure to parental domestic violence during the patients’ childhoods. The older adults without social support involved in their important decision making had more than seven times the odds of having anxiety in comparison with the patients who did have a friend or social support.

When the COPD adults had more than 10 exposures during their childhood to parental domestic violence, their odds for anxiety in comparison to the adults without COPD rose to about five times the risk. The researchers believe that this violence may have triggered a predisposition to anxiety in the patients.

The study “highlights how healthcare providers can play a significant role in identifying and providing promising interventions to reduce anxiety for individuals with COPD, in particular by screening for and addressing pain and functional limitations and targeting those most at risk,” Fuller-Thomson concluded.

Related Videos
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
Understanding the Link Between Substance Use and Psychiatric Symptoms, with Randi Schuster, PhD
Andrew Miller, PhD: Inventor of KarXT Discusses Pivotal EMERGENT-2 Data
© 2024 MJH Life Sciences

All rights reserved.